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Turner syndrome (TS) is associated with a characteristic neurocognitive profile that includes impaired visuospatial/
perceptual abilities. We used a molecular approach to identify a critical region of the X chromosome for neuro-
cognitive aspects of TS. Partial deletions of Xp in 34 females were mapped by FISH or by loss of heterozygosity
of polymorphic markers. Discriminant function analysis optimally identified the TS-associated neurocognitive phe-
notype. Only subjects missing ∼10 Mb of distal Xp manifested the specified neurocognitive profile. The phenotype
was seen with either paternally or maternally inherited deletions and with either complete or incomplete skewing
of X inactivation. Fine mapping of informative deletions implicated a critical region of !2 Mb within the pseudo-
autosomal region (PAR1). We conclude that haploinsufficiency of PAR1 gene(s) is the basis for susceptibility to the
TS neurocognitive phenotype.
Introduction
Turner syndrome (TS), also known as “Ullrich-Turner
syndrome” or “monosomy X,” is a genetic disorder that
occurs in 1/2,500 female births. The complex phenotype
includes ovarian failure, specific physical features (short
stature), and a characteristic neurocognitive profile. Un-
like other common chromosome disorders—for exam-
ple, trisomy 21—TS is typically not associated with gen-
eral mental retardation (Van Dyke et al. 1991). Verbal
abilities are generally normal; however, 45,X girls and
women, as a group, have specific deficits in visuospatial
abilities, visuoperceptual abilities, motor function, non-
verbal memory, executive function, and attentional abil-
ities, when compared with normal females matched for
age, height, IQ, and socioeconomic status (SES) (Waber
1979; Bender et al. 1984; McCauley et al. 1987; Rovet
1991; Ross et al. 1995; Romans et al. 1998).
The etiology of impaired cognition in TS is unknown.
Observed deficits could be due to environmental/ex-
periential, endocrine, or genetic factors. Girls with TS
are short and may have other physical abnormalities
that could indirectly affect their cognitive development.
Sex steroid deficiency may also influence cognitive out-
come. For example, impaired memory ability and motor
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function in children with TS may result from estrogen
deficiency and may improve with estrogen replacement
therapy (Ross et al. 1998, 1999). Cognitive deficits, such
as impaired visuospatial/perceptual skills, may represent
more direct genetic effects. These deficits are relatively
consistent across wide age ranges in females with TS
and are not reversible with estrogen treatment (Downey
et al. 1991; Swillen et al. 1993; Romans et al. 1998).
Furthermore, women with TS who have received estro-
gen replacement have improved verbal memory and
speeded motor performance but retain a verbal IQ– per-
formance IQ (VIQ-PIQ) discrepancy as well as impaired
visuospatial processing, visual memory, and arithmetic
skills (Downey et al. 1991; Swillen et al. 1993; Romans
et al. 1998).
Precedence for a genetic influence on visuospatial cog-
nitive ability comes from the example of Williams syn-
drome, which is due to haploinsufficiency of only a few
genes in a small region of chromosome 7 (7q11.23)
(Frangiskakis et al. 1996). One of these genes, LIM-
kinase1, may be responsible for the deficit in visuo-
spatial construction characteristic of this disorder (Mer-
vis et al. 1999). The LIM-kinase1 gene may be one of
several genes that influence spatial cognitive ability
(Mervis et al. 1999).
TS genes are localized to the sex chromosomes and
are thought to escape X inactivation. Thus, like Wil-
liams syndrome, haploinsufficiency may also explain the
cognitive deficits in TS (Zinn et al. 1993). One way to
deduce the underlying genotype-phenotype relation-
ships in TS is to compare the phenotypes of individuals
missing various portions of one sex chromosome, in
order to assign specific features to “critical regions.” A
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trait maps to a region if deletion of that region accounts
for the variance in that trait. In actuality, most TS traits
are probably due to multiple genes, each contributing
to the phenotypic variance. For example, deletion of the
SHOX gene in the Xp-Yp pseudoautosomal region
(PAR1) accounts for much of the characteristic TS
growth deficit (Rao et al. 1997), and more proximal
Xp gene(s) probably account for most of the remaining
variance in stature (Kosho et al. 1999). Our study of
the physical traits of TS indicated that subjects with Xp
deletion displayed a wide spectrum of TS phenotypes
(Zinn et al. 1998), whereas the only TS feature com-
monly and consistently associated with Xq deletions
was ovarian failure (Geerkens et al. 1994). In the present
study, we extend our findings on subjects with Xp de-
letions to the neurocognitive aspects of TS.
Elsewhere we have demonstrated that discriminant
function analysis (DFA) can be used to identify children
with a defined TS neurocognitive profile (Ross et al.
1997). In the present study, we have extended our DFA
to adults. DFA is a statistical method for deriving a linear
function that optimally weights parameters to permit sen-
sitive and specific differentiation among groups. Al-
though our choice of which cognitive abilities to test was
guided by general knowledge of TS-associated deficits,
the DFA did not assume a priori knowledge as to which
of these deficits best characterizes TS, nor does DFA ex-
plain these deficits. The tasks within the discriminant-
function result, therefore, are unlikely to represent a co-
hesive underlying domain but, rather, they represent a
set of measures that optimally distinguishes subjects with
TS and controls. The results provide a summary statistic
for purposes of phenotype mapping that identifies which
subjects with partial monosomy X have the defined TS-
associated neurocognitive phenotype.
Using the combination of molecular mapping and de-
tailed neurocognitive profiling, we identified a small in-
terval of distal Xp, deletion of which was sufficient for
expression of the defined TS neurocognitive phenotype.
These results set the stage for identification of specific X-
linked gene(s) that influence visuospatial cognitive ability.
Subjects and Methods
Subjects
This study was approved by the Human Studies Com-
mittees at Thomas Jefferson University and The Uni-
versity of Texas Southwestern Medical School. Informed
consent and assent were obtained from all participants
or, in the case of minors, from a parent or legal guardian.
We excluded subjects with sex-chromosome mosaicism,
ring X chromosomes, clinical features of autosomal
aneuploidy in the case of unbalanced X;autosome trans-
locations, or clinical diagnoses of Goltz, Aicardi, or MLS
syndromes in the case of distal Xp deletions. Each sub-
ject had a comprehensive evaluation for TS clinical fea-
tures. Subjects with serum gonadotropin levels in the
castrate range (at least twice the upper limit of normal)
and amenorrhea (if 116 years of age) were determined
to have ovarian failure. Ovarian status was considered
indeterminate in subjects !10 years of age with subcas-
trate gonadotropin levels, because gonadotropins do not
reliably rise to these levels in girls with TS until they are
10 years of age (Conte et al. 1975).
Cytogenetic and Molecular Analyses
Repeat karyotypes were obtained for subjects not
evaluated cytogenetically within the previous 2 years.
For each subject, 20 cells were karyotyped. Lympho-
blastoid cell lines were derived from blood samples by
standard methods (Gilbert 1995). DNA was prepared
from 1 ml of blood, using the Promega Wizard kit. Mo-
lecular cytogenetic analyses for mosaicism and deletion
mapping, using FISH, and analysis of X inactivation
patterns, using the androgen receptor methylation assay,
have been described elsewhere (Allen et al. 1992; Zinn
et al. 1998). FISH probes not described (Zinn et al.
1998) were prepared from PAC clones selected from the
Integrated X Chromosome Database (Leser et al. 1999).
Breakpoints were inferred from data on relatives for
two subjects with familial deletions: SW175 (lymphoblast
transformation failed) and SW105 (blood sample una-
vailable). A subset of breakpoints was further mapped,
using standard techniques, by genotyping subjects and
both parents for polymorphic microsatellite markers ob-
tained from the Genome Database, as described (James
et al. 1998).
Neurocognitive Phenotype Evaluation
The neurocognitive and behavioral assessments in-
cluded tests of general cognition (Wechsler Intelligence
Scale for Children–Revised [WISC-R] and [Wechsler
Adult Intelligence Scale–Revised [WAIS-R]), achieve-
ment (Wide Range Achievement Test [WRAT]), memory
(word list recall, Denman story recall, and recall of the
Rey complex figure), language (token test, Peabody pic-
ture vocabulary test, and Boston naming test), visuos-
patial ability (judgment of line orientation, motor-free
visual perception test, Money street map, test of facial
recognition, Warrington faces, and Gestalt closure), vis-
uomotor ability (test of visual-motor integration and re-
call of the Rey complex figure), and attention and im-
pulsivity (freedom from distractibility from the WISC-R,
tests of variables of attention, and the matching familiar
figures test). These tests are referenced in previous
publications (Ross et al. 1995; Romans et al. 1998). We
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did not analyze subjects with VIQ !69, who were likely
to have pervasive developmental delay.
Statistical Analyses
DFA.—We performed DFA (see below), using the re-
sults of the battery of cognitive tests on our 45,X subjects
with TS and on age-, VIQ-, and SES-matched normal
female controls (Ross et al. 1997). Separate analyses
were performed for the children, aged 7–16.9 years, and
for the adults, aged 17–55 years, because certain tasks
are age specific. Results used to develop the TS visuo-
spatial/perceptual neurocognitive (VSPN) score were
then used to identify which subjects with Xp deletion
had the TS neurocognitive phenotype.
From the above tasks, to select 20 variables that dif-
fered significantly ( ) between subjects with TSP ! .001
and controls, 180 neurocognitive variables were first
tested by analysis of variance, with age and SES as cov-
ariates. We then applied a stepwise DFA to those 20
variables, using the Mahalanobis distance formula to
maximize the n-dimensional distance between group
centroids. This analysis identified specific neurocognitive
variables that optimally separated the TS and control
groups and estimated the coefficients of the linear dis-
criminant function (DF).
The DFA in children was based on the neurocognitive
evaluations of 83 girls with TS and 165 healthy control
girls, aged 7–16.9 years (Ross et al. 1997). The variables
selected by the DFA for children were the following:
WISC-R freedom from distractibility: standard score;
WISC-R picture completion: standard score; test of facial
recognition: raw score; Rey Osterreith figure copy: raw
score; motor free visual perception test: performance
quotient; Beery test of visual motor integration: standard
score; and the WRAT—Reading (WRAT-R): standard
score. The sensitivity of the resulting DF was 0.78, and
the specificity was 0.84.
The DFA in adults was based on the neurocognitive
evaluations of 51 women with TS and 37 healthy control
women, aged 17–55 years. All controls had normal men-
strual histories and were evaluated in the follicular phase
of their cycles. The groups were well matched for age,
VIQ, race, and SES. The variables selected by the DFA
for the adults were the following: WAIS-III arithmetic,
picture completion, and picture arrangement subtests;
Rey figure organization; semantic fluency; Warrington
faces; Lafayette pegboard; Money street map—timed
performance; and facial affect perception—anger. The
sensitivity of the DF, using the above results, was 0.86,
and the specificity was 1.00.
Derivation of the VSPN.—On the basis of the DFA
results, we developed a formula by converting the stan-
dardized coefficients to integers and revising the scale of
the linear DF separately for the children and the adults.
We imposed minimum and maximum limits of 2 SD
for any particular test result, so that no single result
would unduly bias the modified DF score, which was
the VSPN. The sensitivity and specificity of the VSPN
score depend on the cutoff value chosen. We chose, a
priori, 0.0 as the VSPN cutoff for both children and
adults, so as not to influence, post hoc, the sensitivity
and specificity of the VSPN score results. We do note
that the cutoffs could be changed to minimize the chance
of falsely identifying a subject as having the typical TS
neurocognitive phenotype, at the expense of reduced
sensitivity, but false positives would be much worse than
false negatives for mapping a rare trait.
In accordance with the original children’s DFA (20),
the freedom from distractibility z-score result (the high-
est discriminating variable) was weighted by a factor of
2, and the other six test z-score results were weighted
by a factor of unity. The VSPN score was then adjusted
for the z score of VIQ, to take into account the effect
of general cognitive ability and to reduce the correlation
of the VSPN score with VIQ. VIQ did not correlate
significantly with the VSPN score ( , ).rp .06 Pp .14
The sum of the seven weighted z scores yielded VSPN
scores in a range of 12 to 12 for the children. The
mean VSPN scores for the TS and control populations
differed significantly ( vs. ,3.1 3.6 2.5 3.3 P !
)..0001
The VSPN cutoff score of 0.0 defined the TS neu-
rocognitive phenotype in children. By this criterion, 102/
132 of the 45,X subjects and 45/203 of the female con-
trols had the TS neurocognitive profile, yielding a
sensitivity of 0.78 and a specificity of 0.78.
For the adults, the Money time z score, semantic flu-
ency z score, Warrington faces z score, and timed peg-
board completion–z score results were weighted by a
factor of 2 (the highest discriminating variables) and the
other five test z-score results were weighted by a factor
of unity. The VSPN score was then adjusted for the z
score of VIQ, to take into account the effect of general
cognitive ability and to reduce the correlation of VSPN
score with VIQ. The VSPN score did not correlate with
VIQ ( , ). The sum of the seven weightedrp .13 Pp .23
z scores yielded VSPN scores in the range of 16.0 to
16.0. The mean VSPN score and its component results
differed significantly for the TS and control populations
( vs. , ).4.6 3.6 4.8 4.4 P ! .0001
The VSPN cutoff score of 0.0 defined the TS neu-
rocognitive phenotype in adults. By this criterion, 46/51
45,X subjects and 7/37 female adult controls were iden-
tified as having the TS neurocognitive profile, yielding
a sensitivity of 0.90 and a specificity of 0.81.
Linear regression analysis.—Using multiple regression
analysis, we converted adult VSPN scores to the same
scale as child scores, so that both sets of data could be
incorporated into a single analysis. There were 1200
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Table 1
Subjects with Nonmosaic Partial Monosomy Xp: VIQ, VSPN Score, Height z score, and Ovarian Status
SW No.
Age
(years) Karyotype (p deletion) Height SDa Ovarian Failureb VIQ
VSPN
Score
TS
Cognitive
Phenotypeb
Deletion of distal Xp
in Xp children
74 13 46,X,del(X)(p11.21) 3.3  91 0.2 
75 13 46,X,del(X)(p11.3) 2.2  101 1.4 
80 13 46,X,del(X)(p11.4) 2.4 a  103 6.4 
86 11 46,X,der(X)t(X;X)(p11;q24) 1.2  75 0.1 
92 7 46,X,del(X)(p11.23) 2.4 Indeterminate 90 9.0 
93 10 46,X,del(X)(p11.23) 3.5  123 3.7 
96 16 46,X,del(X)(p21.2) 1.2  64
97 13 46,X,del(X)(p21.2) 0.4  86 4.1 
106 7 46,del(X)(p.22.3) 1.6 Indeterminate 114 9.4 
112 11 46,X,del (X)(p11.2) 3.9  115 0.5 
122 16 46,X,del(X)(p22.1) 2.7  106 2.5 
145 14 46,X,del(X)(p22.1) 1.4  90 2.7 
146 12 46,X,del(X)(p22.1) 0.4  96 1.4 
151 7 46,X,del(X)(p11.2) 2.5 Indeterminate 84 0.0 
161 9 46,X,del(X)(p11.23) 3.3  106 4.0 
202 11 46,X,del(X)(p11.4) 0.3  96 0.7 
216 7 46,X,der(X)t(X;Y)(p22.3;q11.2)maternal 2.1 Indeterminate 106 0.5 
241 7 46,X,der(X)t(X;Y)(p22.3;q11.2)paternal 1.5 Indeterminate 79 1.0 
242 7 46,X,der(X)t(X;Y)(p22.3;q11.2)paternal 1.3 Indeterminate 92 1.6 
Deletion of distal Xp
in Xp adultsc
16 17 46,Xder(X)t(X;1)(p11;q44)maternal 3.5  88 1.6 
46 34 46,X,del(X)(p21.2) 0.3  96 3.4 
71 20 46,X,del(X)(p11.2) 2  93 9.4 
85 45 46,X, del(X)(p11.2) 3.4  100 1.1 
105 25 46,Xder(X)t(X;1)(p11;q44)maternal 3.3  90 1.4 
109 46 46,X,del(X)(p11.1) 4.7  111 3.1 
111 20 46,X,del(X) (p11.21) 3.3  118 0.2 
144 36 46,X,del(X)(p22.1) 0.6  86 2.4 
157 42 46,X, del(X)(p22.31p22.33)b 0.9  100 0.9 
174 22 46,X,der(X)t(X;A)(p22.3;p11.2)maternal 0.8  76 5.1 
175 40 46,X,der(X)t(X;A)(p22.3;p11.2) 1.8  69 1.6 
211 20 46,X,del(X)(p11.23) 3.6  104 0.4 
217 29 46,X,der(X)t(X;Y)(p22.3;q11.2) 1.4  96 3.7 
Nondeletion of distal
Xp in Xp adultsb
190 40 46,X,del(X)(p22.1)b 0.8  100 12.1 
239 31.2 46,X,del(X)(p11.2p11.4) 1.7  89 3.2 
a MP height z score adjusted for midparental height, unavailable for one subject who was adopted.
b A plus sign () indicates presence, and a minus sign () indicates absence.
c Classification based on FISH results (fig. 1).
controls and TS subjects in our larger database with both
adult and child VSPN scores, and from these subjects
we performed a simple regression analysis. To minimize
variability, we converted the adult scores to child scores,
since there were more children than adults in our anal-
ysis. The regression formula for the adult score conver-
sion was [adult score # 0.41  2.1], ,rp .6 P !
..0001
Results
The study population included 34 females with partial
monosomy for Xp due to terminal or interstitial dele-
tions or unbalanced translocations (table 1). There was
ascertainment bias in favor of short stature or ovarian
failure. There may also have been bias toward lower
overall cognitive ability (mean ), sinceVIQp 95 14
individuals with intellectual impairment are more likely
to be karyotyped, but there was no apparent bias with
regard to selective cognitive deficits. Subjects were white
(28), African American (2), Hispanic (3), and Asian (1)
and had an age range of 7–46 years. Thirteen subjects
were members of kinships; other subjects were unrelated
(fig. 1).
A summary of subjects’ height z score (adjusted for
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Figure 1 Mapping of subjects with nonmosaic Xp deletions. Related subjects are indicated. Bars indicate regions present. Shaded bars
indicate subjects with TS neurocognitive phenotype. Approximate physical distances are shown on the left. Deletions are grouped according to
results of FISH, with markers shown on the right; order of subjects within groups is arbitrary.
midparental height), ovarian status, and neurocognitive
results (VIQ and VSPN scores) is shown in table 1. No
VSPN score was calculated for one subject (SW96) with
VIQ !69. There was no obvious relationship between
VIQ and the position or extent of Xp deletion. When
we applied the criterion of 0.0 (children or adult) SD
units for the TS-associated neurocognitive phenotype,
8 (44%) of 18 children with the Xp deletion and 7
(54%) of 13 adults with the Xp deletion, with overlap-
ping deletions of distal Xp (15/31 total), were positive
(table 1). These included subjects with either large or
small deletions; all were missing a portion of distal Xp
(fig. 1). By comparison, 78% of 45,X children (np
) and 90% of 45,X adults ( ) had the defined132 np 51
neurocognitive phenotype. The proportion of subjects
with Xp deletion meeting the VSPN criteria was less
than that of 45,X subjects (Fisher’s exact test, 2-tailed,
and for children and adults,Pp .007 Pp .006
respectively).
VIQ and PIQ varied widely (69–114 for VIQ and
77–106 for PIQ) among the subjects who met the VSPN
criteria. Thus, individual VIQ results did not predict
who had the TS-associated neurocognitive phenotype.
For example, SW85 and SW190 both had average VIQ
scores of 100, but SW190 had the highest VSPN score
(12.1), whereas SW85 had one of the lower VSPN
scores (1.1).
Molecular cytogenetic breakpoints are indicated sche-
matically in figure 1. Twenty-eight breakpoints were
reported (Zinn et al. 1998). Seven breakpoints !10 Mb
from the telomere were not differentiated by initial FISH
analyses. Because deletion of this region was associated
with the neurocognitive phenotype, we investigated dis-
tal Xp breakpoints (fig. 1, subjects SW157-SW106 and
SW190) in more detail. We obtained DNA samples from
both parents of SW106, SW241/SW242, SW216,
SW217, and SW190 and assayed subjects for loss of
heterozygosity of polymorphic microsatellite markers.
We also tested additional distal Xp22.3 FISH markers.
The results are shown in figure 2. SW174 and SW175
(mother and daughter), both of whom have the TS neu-
rocognitive phenotype (VSPN scores 1.0 and 1.6,
respectively), had the smallest deletion. Both had de-
letions of SHOX but not RPCI3-431I1, which is ∼1.9
Mb from the telomere, and both were fertile with ap-
parently normal ovarian function. Four of the remain-
ing six subjects had the TS neurocognitive phenotype.
Thus, six of eight subjects with the most distal deletions
of Xp met the statistical criteria for the TS cognitive
phenotype. Two pairs of these subjects were mother/
daughter pairs and one pair was mz twins. All had con-
cordant cognitive phenotypes. If only one subject from
each pair of relatives is counted, the frequency of the
TS cognitive phenotype in the distal Xp deletion subjects
is 80% (4/5).
Two adults (SW190 and SW239) had interstitial de-
letions of Xp that did not include SHOX or PAR1.
Neither had the TS neurocognitive phenotype (VSPN
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Figure 2 The neurocognitive phenotype maps to distal Xp. Data for deletion mapping, X inactivation, parent of origin (p p paternal,
m p maternal), and neurocognitive phenotype are shown for the eight subjects with the smallest terminal deletions and for two subjects with
interstitial deletions (fig. 1). Black lines indicate regions not deleted; gray lines indicate uncertainty. Underscored subjects indicate mother-
daughter pairs; double-underscored subjects indicate mz twins.
scores 12.1 and 3.2, respectively). SW239 had short
stature and ovarian failure, whereas SW190 did not.
Ovarian failure was clearly neither necessary nor suf-
ficient for the TS cognitive phenotype, since at least
three adult subjects with small distal deletions and with
the phenotype did not have ovarian failure (SW174,
SW175, and SW157).
All the deletions in subjects with the TS neurocog-
nitive phenotype included the SHOX stature locus. To
assess whether the cognitive phenotype was related to
stature, we performed regression analysis of the VSPN
score versus height SD units, using the entire popula-
tion. There was no significant correlation ( ,rp .19
), which suggests that the TS cognitive pheno-Pp .30
type is due to a genetic effect independent of stature.
We also performed regression analysis, merging the chil-
dren and adults (45,X and partial-deletion populations)
of the VSPN score versus age. There was a small but
significant relationship between the VSPN score and age
in a positive direction ( and ), account-rp .24 P ! .001
ing for ∼4% of the variance.
We examined the parent of origin of the X chro-
mosome deletions in subjects SW157–SW106. SW174
and SW216 inherited unbalanced translocations from
their mothers, and SW241 and SW242 inherited a de
novo unbalanced X;Y translocation from their father
(case 2, Joseph et al. 1996). Microsatellite marker anal-
ysis allowed us to determine the parent of origin of the
X deletion for four of the remaining six subjects. The
deletion was paternally inherited in three subjects
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(SW106, SW241, and SW239) and maternally inherited
in one (SW190). There was no absolute relationship
between the parental origin of the X chromosome de-
letion and the presence or absence of the TS neurocog-
nitive phenotype (fig. 2).
To determine whether X inactivation differences
might play a role in the neurocognitive phenotype, we
tested the pattern of X inactivation in our subjects. One
subject (SW96) was uninformative for the androgen re-
ceptor polymorphism, and blood DNA was unavailable
from seven subjects. Of the remaining 26 subjects, all
with sequences deleted proximal to Xp22.3 (fig. 1,
SW144–SW80) had 195% skewed X inactivation, with
the deleted X presumably inactive (data not shown). By
contrast, five of the seven subjects with distal Xp22.3
deletions (fig. 1, SW157–SW216) did not have highly
skewed inactivation (fig. 2). Of these five, four had the
TS neurocognitive profile and one did not.
Discussion
Our data suggest that the basis for the defined visuo-
spatial/perceptual deficit associated with monosomy X
is genetic. We used a molecular approach and genotype-
phenotype correlations to identify a critical region of the
X chromosome for neurocognitive aspects of TS. We
studied a population of females with nonmosaic dele-
tions spaced along the short arm of the X chromosome.
Subjects missing only distal Xp22.33, at a minimum,
manifested the defined TS-associated neurocognitive
profile. By contrast, two subjects with interstitial Xp
deletions sparing distal Xp22.33 did not have the phe-
notype. Furthermore, there was no apparent relationship
between the TS neurocognitive phenotype and either
stature or ovarian status. We conclude that the defined
TS neurocognitive phenotype is genetic in etiology and
maps to distal Xp22.3. The smallest deletion associated
with the TS neurocognitive phenotype was in a mother
and daughter missing !2 Mb of terminal Xp. This de-
letion fell within the 2.6 Mb Xp-Yp PAR1, where the
sex chromosomes pair and recombine during male mei-
osis. Genes within this region escape X inactivation, so
that both XY males and XX females express equivalent
levels. Thus, deletions of the Y copy of PAR1 could be
expected to cause TS-associated neurocognitive deficits
in males. However, the phenotype may be sex-limited
because of positive androgen effects on visuospatial
abilities.
There are seven known genes in the minimal PAR1
critical region. They include PGPL, SHOX, CSF2RA,
IL3RA, ANT3, ASMT, and ASMTL. PGPL encodes a
putative GTP-binding protein that is ubiquitously ex-
pressed (Gianfrancesco et al. 1998). SHOX (or PHOG)
encodes a homeodomain protein; haploinsufficiency of
SHOX causes short stature or Leri-Weill dyschondros-
teosis (Rao et al. 1997; Belin et al. 1998; Shears et al.
1998). One isoform, SHOXa, is expressed in many em-
bryonic tissues, including brain (Rao et al. 1997), and
it is tempting to speculate that the gene functions in
nervous system development. However, intellectual im-
pairment is not seen in patients with Langer mesomelic
dwarfism (Jones 1997), in whom there are homozygous
SHOX mutations. CSF2RA and IL3RA encode sub-
units of cytokine receptors that function in hemato-
poiesis (Kitamura et al. 1991). ANT3 encodes a ubiq-
uitous ADP/ATP translocase that functions in cellular
energy metabolism (Schiebel et al. 1993). ASMT en-
codes acetylserotonin methyltransferase (hydroxyin-
dole-O-methyltransferase; EC 2.1.1.4 ), which catalyzes
the final step in the synthesis of melatonin and is abun-
dant in the pineal gland and retina (Yi et al. 1993). On
the basis of an association between psychoses and su-
pranumerary sex chromosomes (Crow et al. 1988) and
one linkage study of schizophrenia (Collinge et al.
1991), ASMT was proposed as a candidate gene for
psychiatric disorders. ASMTL is a ubiquitously ex-
pressed homolog of ASMT, whose precise biochemical
function is not known (Ried et al. 1998).
There are several hypotheses to explain the pheno-
typic effects of TS (Epstein 1988). The simplest expla-
nation is that the phenotype occurs in individuals having
half the normal dose of X-linked genes and thus sub-
normal levels of gene products (Epstein 1993). X-in-
activation differences or imprinting could affect the ob-
served phenotype. All but four subjects with the very
smallest Xp deletions had completely skewed X inac-
tivation, with the deleted X presumably inactive. In-
complete skewing associated with similar deletions has
been reported by others (Schaefer et al. 1993; Thomas
et al. 1999). We excluded subjects with clinical abnor-
malities, such as Goltz syndrome or MLS syndrome,
that are thought to be due to nullisomy for part of the
deleted X, which is active in a portion of cells (Ballabio
et al. 1989). Also, we observed the TS neurocognitive
profile in subjects with either complete or incomplete
skewing. Thus, X-inactivation differences are unlikely
to explain our data. The lack of association with X
inactivation is consistent with a pseudoautosomal locus,
since PAR1 genes appear to fully escape inactivation.
Last, we observed the defined TS neurocognitive phe-
notype in subjects with either maternal or paternal de-
letions, indicating that it is not imprinted. This finding
is consistent with that of Skuse et al. (1997), who re-
ported evidence of imprinting for social function but
not for visuospatial abilities.
Certain study limitations should be addressed. First,
the proportion of subjects with the Xp deletion who
met the VSPN criteria was less than the proportion of
45,X subjects who met the criteria. This difference may
be due to gene(s) elsewhere on the X chromosome that
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contribute to TS neurocognitive deficits or to hormonal
differences. Subjects with partial deletions are less likely
than 45,X subjects to have ovarian failure (Zinn et al.
1998) or estrogen deficiency that may also affect neu-
rocognitive abilities (Ross et al. 1998).
Second, our genotype-phenotype analysis assumes
that haploinsufficiency of one gene on Xp is a major
determinant of the defined TS-associated VSPN deficit.
We do not presume to understand the entire genetic
basis for the TS cognitive profile. It would be inaccurate
to assume that the only deficit in TS is in visuospatial
abilities or that each specific domain of deficit is ge-
netically determined. Likewise, it would be an oversim-
plification to expect a 1:1 relationship between deletion
of a specific gene and individual TS deficits because of
the multifactorial nature of these deficits and of normal
cognitive function. In addition, autosomal genes un-
doubtedly influence these cognitive abilities. For ex-
ample, haploinsufficiency of a gene on chromosome 7,
possibly LIM-kinase1, impairs visuospatial construc-
tion abilities in Williams syndrome (Frangiskakis et al.
1996; Mervis et al. 1999). In addition, other genetic
determinants that are not specific for visuospatial ability
may have an impact on this trait. Identical deletions in
Williams syndrome may be associated with varying vis-
uospatial impairments (Mervis et al. 1999).
There are also study-related issues concerning ascer-
tainment bias and mosaicism. Ascertainment bias is un-
avoidable in studies of rare chromosomal abnormalities.
For example, some of our most informative subjects
were ascertained because of chromosomal abnormali-
ties in a relative. However, we are not aware of any
bias with regard to selective neurocognitive features. As
with other TS phenotype-mapping studies, mosaicism
could confound apparent genotype-phenotype correla-
tions. Although mosaicism can never be completely ex-
cluded, the lack of correlation with height SD, ovarian
failure, or other TS physical features (data not shown)
argues that the VSPN score is unlikely to reflect occult
mosaicism.
Questions may arise about the use of the DFA, the
variables chosen, and testing of individuals in a wide
age range. We used DFA in defining the TS-associated
neurocognitive phenotype. DFA has been applied to ge-
netic disorders to describe facial features of Down syn-
drome (Allanson et al. 1993) and TS (Kaiser et al. 1996).
The neurocognitive phenotype associated with TS is not
a uniform phenotype but, instead, represents increased
susceptibility to certain defined deficits compared with
the phenotype of normal unaffected individuals. We de-
veloped the VSPN score as a tool for description of the
phenotype. We then applied this tool to subjects with
partial deletions, to define the genes associated with the
phenotype.
The VSPN cutoff had relatively high sensitivity but
lacked 100% specificity because the TS and control pop-
ulations have some overlap, particularly with lower-
functioning normal individuals. If the specificity is fur-
ther increased, then the sensitivity is further decreased,
and individuals with the defined TS cognitive phenotype
and associated gene deletion would not be identified.
There was a small but significant relationship between
VSPN score and age. The small positive correlation of
VSPN score with age does not change the discriminatory
power of the DF, because it applies uniformly to the
population.
We performed separate analyses for children and
adults because of the wide age range. Many of the cog-
nitive domains and component tasks in the children’s
and the adults’ VSPN scores are similar and tend to
measure visuospatial perception. Visual memory, visual
attention, and visual discrimination are all used in vis-
uospatial perception, which is not a unitary function
but rather has multiple components that are both an-
atomically and functionally distinct. Likewise, visuo-
spatial/perceptual ability is influenced by multiple genes.
Some VSPN tasks have an additional visuomotor com-
ponent, and one has an affect (anger)-recognition com-
ponent. These areas are typically impaired in children
with TS and in adults. Additional domains and asso-
ciated tasks that have been found to be impaired in
subjects with TS did not reach statistical significance in
the DFA.
Certain tasks that discriminated between children
with TS and controls did not discriminate between the
adults with TS and controls. Also, certain domains (spa-
tial construction and attention) found to be impaired
in children with TS appear to be less impaired in adults
with TS. The reasons for this are likely task related.
First, some tasks may have ceiling effects when given
to adults. Second, the specific strategy for problem solv-
ing in children probably differs from that in adults.
Adults are more able to compensate for spatial impair-
ment than are children. Last, there may be more im-
provement in certain cognitive abilities in adults with
TS than in children with TS.
Most tasks in both the children’s and the adult VSPN
scores depend, to a great extent, on processing capa-
bilities that are thought to be lateralized to the right
cerebral hemisphere. Neuroimaging studies of subjects
with TS have suggested a hypothesis of right cerebral
dysfunction in TS. However, the WRAT-R test in the
children’s VSPN score and semantic fluency in the adult
VSPN score depend, at least in part, on the functional
capacity of the left parietal region. It is perhaps signif-
icant that this is the major left-hemispheric region
shown to be abnormal in MRI studies of subjects with
TS (Reiss et al. 1995). Other tasks included in the chil-
dren’s VSPN score may also have substantial left-hem-
isphere underpinnings, including the Freedom from Dis-
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tractibility (third factor) from the WISC-R. Also, the
Test of Facial Recognition may be coupled to verbal
capability, again suggesting left-hemisphere involve-
ment. Last, the WAIS arithmetic subtest from the
adult VSPN score is likely right- and left-hemispheric
dependent.
Several theories have been proposed to explain how
abnormal brain development in TS leads to abnormal
cognitive development. Some investigators postulate an
anomalous hemispheric maturation, such that the right
hemisphere is underdeveloped relative to the usual
asymmetry seen in normal, age-matched control females
(Money 1973; Netley et al. 1982). Other investigators
and our previous findings support an alternative hy-
pothesis for the etiology of the neurocognitive profile
of patients with TS, which is consistent with multifocal
brain dysfunction (Hier 1980; Pennington et al. 1985;
Ross et al. 1995).
The constellation of neurocognitive deficits observed
in TS is most likely multifactorial and related to a com-
plex interaction between genetic abnormalities, hor-
monal deficiencies and replacement, and other unspe-
cified determinants. We do not expect a single gene to
affect only a single cognitive domain. Rather, its product
influences brain structure and function, which, in turn,
are modified by biochemical and experiential influences.
Thus, a gene that is highly associated with one specific
cognitive function is not precluded from influencing
other aspects of cognitive function. Most genes involved
in cognitive function probably influence multifocal as-
pects of brain development. Thus, deletion of a gene on
distal Xp may influence the development of visuospatial
ability to the greatest extent but also may affect diverse
brain regions and, thus, other cognitive abilities. The
ultimate cognitive outcome in a female with TS is the
result of these features plus the individual’s unique non-
TS cognitive profile, environment, and education. This
study suggests the origin of the primary genetic event
and begins to reduce the genetic complexity of TS to
individual gene determinants. Future studies will in-
volve identification of TS neurocognitive gene(s) and
determination of whether variation at this locus influ-
ences cognitive abilities in the general population.
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